Neurology Today in 5

By: American Academy of Neurology
Listen for free

  • Summary

  • Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.
    2024
    Show more Show less
Hygiene & Healthy Living Physical Illness & Disease
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.

    Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.
    Jan 2 2025

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on the latest Cochrane review of magnesium sulfate to prevent cerebral palsy; a novel mRNA system for gene therapy for muscular dystrophies, and the perception of CTE and suicidality risk in retired NFL players.

    Show more Show less
    5 mins
  • Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

    Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
    Dec 19 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on proposed updated criteria for diagnosing MS before symptoms manifest, the use of large language models to address administrative burden with electronic medical records, and the growth of training programs in neonatal neurocritical care.
    Show more Show less
    5 mins
  • 3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

    3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
    Dec 5 2024

    In this week’s podcast, Neurology Today’s editor-in-chief highlights articles on a study highlighting three-year outcomes for patients with anti-NMDAR encephalitis, an analysis comparing the diagnostic efficacy of skin biopsies vs. CSF tests for human prion diseases, and the ways in which a graduate degree in public health and/or business administration can shape career pathways for neurologists.

    Show more Show less
    5 mins

What listeners say about Neurology Today in 5

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available